May 21, 2024
BOSTON — Primary care clinicians caring for patients with intellectual and developmental disabilities often recommend guardianship, a responsibility with life-altering implications. But only approximately 30% of […]
May 21, 2024
Collaborating with States FDA’s compounding program closely collaborates with state officials in a variety of ways, including: sharing information about compounders who engage in poor practices […]
May 21, 2024
Effective communication among ANDA applicants, DMF holders, and FDA is essential for reducing the likelihood of potential problems that could delay approvals. The reauthorization of the […]
May 21, 2024
GDUFA Guidance for Industry To view all GDUFA guidances, go to the Guidances for Drugs page, enter “GDUFA” in the search box, and under “Filter by,” […]
May 21, 2024
A noninvasive spinal stimulation device safely improves upper-extremity function in people with a cervical spinal cord injury (SCI), results of a prospective nonsignificant risk trial suggest. […]
May 21, 2024
5/21/2024 Drug Approval Package: JAYPIRCA 11/9/2023 First Interchangeable Exclusivity Expiration Memorandum for Cyltezo October 3, 2023 (PDF – 1.41MB) 5/15/2023 Adverse event report for Syfovre (PDF […]
May 21, 2024
Delivery Method: VIA EMAIL CONFIRMED DELIVERY Product: Drugs Recipient: Recipient Name Mr. Jose L. Escobedo Recipient Title Manufacturing Operations Manager Central Admixture Pharmacy Services, Inc. 2200 […]
May 21, 2024
There is an “urgent need” to exploit the potential of social media to educate and positively influence young people with scientific information on obesity, according to […]
May 21, 2024
TOPLINE: For low-risk pregnancies, the most accurate timing of ultrasound for diagnosing foetal structural anomalies before 24 weeks’ gestation appears to be combined scanning during the […]